Total Funding
35
57
Total FundingVenture - Series Unknown raised
Growth Score
1 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
124130
Biotechnology company developing a natural elastin dermal filler with its proprietary tissue engineering technology development platform
Thomas Ford: Chief Executive Officer
About the Company
Our goal is to unlock the therapeutic potential of natural elastin. Our initial curiosity was ignited by studying elastin-rich mitral valve transplants. The question that emerged was simple: “Is it possible to isolate and purify elastin for a range of other applications?” The answer was YES. TruElastin has since developed and patented a novel
development platform for reliably producing natural elastin biomaterials. This innovation led us to develop our first groundbreaking device candidate, a novel dermal filler that we call TEL219.
It was established in Chatham, New Jersey in 2010.
